← Inspire Medical Systems, Inc. INSP
Market Price
$57.10
Market Cap
$1.68B
P/E Ratio
N/A
Revenue (FY 2025)
↑13.6% YoY
$911.98M
3-Yr CAGR: 30.8%
Net Income
↑171.8% YoY
$145.42M
Net Margin: 15.9%
Free Cash Flow
↓-13.9% YoY
$78.48M
FCF Yield: 4.68%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
18.6%
ROA: 16.0%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (INSP)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2017 | $28.6M | — | $22.5M | $-17.5M | — | — | — | $-15.8M | $-16.2M | — |
| FY 2018 | $50.6M | +77.1% | $40.5M | $-21.8M | -24.7% | — | — | $-18.7M | $-18.9M | -16.9% |
| FY 2019 | $82.0M | +62.2% | $68.4M | $-33.2M | -52.3% | — | — | $-32.8M | $-35.6M | -87.8% |
| FY 2020 | $115.4M | +40.6% | $97.8M | $-57.2M | -72.1% | — | — | $-53.0M | $-55.5M | -56.0% |
| FY 2021 | $233.4M | +102.3% | $200.1M | $-42.0M | +26.5% | — | — | $-20.1M | $-24.8M | +55.3% |
| FY 2022 | $407.9M | +74.7% | $341.7M | $-44.9M | -6.8% | — | — | $11.6M | $2.5M | +110.0% |
| FY 2023 | $624.8M | +53.2% | $528.2M | $-21.2M | +52.9% | — | — | $24.7M | $1.0M | -58.6% |
| FY 2024 | $802.8M | +28.5% | $679.8M | $53.5M | +353.0% | — | — | $130.2M | $91.1M | +8,798.7% |
| FY 2025 | $912.0M | +13.6% | $778.8M | $145.4M | +171.8% | — | — | $117.0M | $78.5M | -13.9% |
Valuation
Market Price
$57.10
Market Cap
$1.68B
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
2.11
FCF Yield
4.68%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
85.39%
Operating Margin
5.59%
Net Margin
15.95%
Return on Equity (ROE)
18.62%
Return on Assets (ROA)
16.03%
Asset Turnover
1.01x
Revenue 3-Yr CAGR
30.77%
Financial Health & Liquidity
Current Ratio
99.99
Cash Ratio
1,007.82
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$104.81M
Total Debt
N/A
Book Value / Share
$27.11
Cash Flow Efficiency
Operating Cash Flow
$116.98M
Capital Expenditures (CapEx)
$38.50M
Free Cash Flow
$78.48M
OCF / Revenue
12.83%
FCF / Revenue
8.61%
FCF 3-Yr CAGR
216.60%
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$27.11
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$907.32M
Total Liabilities
$907.32M
Stockholders' Equity
$781.16M
Current Assets
$10.40M
Current Liabilities
$104.00K